Johnson & Johnson (JNJ)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
147.55-0.85 (-0.57%)
At close: 4:00PM EDT
| Previous close | 148.40 |
| Open | 148.40 |
| Bid | 146.50 x 1200 |
| Ask | 147.54 x 900 |
| Day's range | 146.50 - 149.25 |
| 52-week range | 109.16 - 157.00 |
| Volume | 4,835,493 |
| Avg. volume | 6,866,521 |
| Market cap | 388.473B |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | 25.96 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 4.04 (2.72%) |
| Ex-dividend date | 24 Aug 2020 |
| 1y target est | N/A |
- Investing.com
Asian Stocks Down Over Mixed U.S. Economic Data and Stall in Stimulus Measures
By Gina Lee
- Motley Fool
Why Moderna Stock Is Slipping Today
What happened Shares of Moderna (NASDAQ: MRNA) are slumping today, down 3.9% as of 11:29 a.m. EDT. The biotech reported its second-quarter results before the market opened. However, they don't appear to be the reason behind the decline in Moderna's stock.
- Reuters
U.S. to pay $1 billion for 100 million doses of J&J's COVID-19 vaccine candidate
The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million the U.S. government promised to J&J for vaccine development in March. J&J is studying both one and two-dose regimens of its vaccine.
© 2020 Verizon Media. All rights reserved.
